The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance

DE Biancur, AC Kimmelman - … et Biophysica Acta (BBA)-Reviews on …, 2018 - Elsevier
Pancreatic ductal adenocarcinoma (PDA) is an aggressive cancer that is highly refractory to
the current standards of care. The difficulty in treating this disease is due to a number of …

The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

DE Biancur, AC Kimmelman - Biochimica et Biophysica acta …, 2018 - europepmc.org
Pancreatic ductal adenocarcinoma (PDA) is an aggressive cancer that is highly refractory to
the current standards of care. The difficulty in treating this disease is due to a number of …

[HTML][HTML] The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance

DE Biancur, AC Kimmelman - Biochimica et biophysica acta …, 2018 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is an aggressive cancer that is highly refractory to
the current standards of care. The difficulty in treating this disease is due to a number of …

[引用][C] The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance

DE Biancur, AC Kimmelman - … et Biophysica Acta (BBA)-Reviews on …, 2018 - cir.nii.ac.jp
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance

DE Biancur, AC Kimmelman - … et biophysica acta …, 2018 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is an aggressive cancer that is highly refractory to
the current standards of care. The difficulty in treating this disease is due to a number of …

The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

DE Biancur, AC Kimmelman - Biochimica et Biophysica acta …, 2018 - europepmc.org
Pancreatic ductal adenocarcinoma (PDA) is an aggressive cancer that is highly refractory to
the current standards of care. The difficulty in treating this disease is due to a number of …